A 48-year-old man with a first-degree family history of gastric cancer underwent esophagogastroduodenoscopy for persistent dyspepsia. Standard white-light imaging (WLI) showed a well-distensible stomach with preserved folds and only mild mucosal edema, with no identifiable focal lesions.When the examination was repeated using high-definition virtual chromoendoscopy with blue-light imaging (BLI) and optical magnification, the stomach appeared truly “under a different light.” Multiple pale, map-like areas were visible in both body and antrum, consistent with gastric intestinal metaplasia (GIM). Endoscopic risk assessment using the Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) yielded a score of 9, indicating extensive metaplastic involvement and aligning with the high-risk category defined by MAPS III criteria.Careful inspection of the lesser curvature of the gastric body revealed an 8–10 mm depressed lesion (Paris 0-IIc), completely invisible under WLI. In BLI with magnification, the lesion displayed features typical of early gastric neoplasia: loss of the normal microsurface pattern (MS), irregular microvascular architecture (MV), and a sharply defined demarcation line separating normal from abnormal mucosa. These findings fulfilled the diagnostic criteria of the Magnifying Endoscopy Simple Diagnostic Algorithm for Gastric Cancer (MESDA-G), based on the validated vessel-plus-surface (VS) classification system.Targeted biopsies confirmed intraepithelial neoplasia (low-grade dysplasia, intestinal phenotype type I). Random biopsies from antrum, angulus and body documented chronic inflammation, extensive intestinal metaplasia (OLGIM IV) and severe glandular atrophy (OLGA IV), delineating a diffusely high-risk mucosal background.Lesion marking, circumferential incision and controlled submucosal dissection were all performed using a Hybrid Knife, achieving complete en-bloc resection without immediate adverse events. Post-procedural assessment confirmed an intact muscularis propria and radical excision.This case highlights the diagnostic superiority of advanced endoscopic imaging over standard WLI. The integration of BLI, optical magnification and structured classification systems (EGGIM and MESDA-G) enabled identification of an early neoplastic focus entirely missed by conventional imaging. MAPS III emphasizes the importance of high-quality endoscopy, supported by advanced imaging techniques for the systematic evaluation of atrophy and metaplasia; in this patient, these principles facilitated timely diagnosis and curative treatment.Advanced imaging does not merely change what the mucosa looks like: it changes what can be diagnosed. For this reason, adequate training is essential for endoscopists to fully master and exploit the potential of these technologies.